低分子肝素治疗急性脑梗死30例临床研究

The treatment of acute cerebral infarction with low molecular weight heparin

目的：观察低分子肝素（速避凝）治疗急性脑梗死的疗效及安全性。方法：对６０例起病在４８小时内的急性脑梗死患者随机分为治疗组和对照组，分别给予低分子肝素及普通治疗。结果：治疗组比对照组治愈率（Ｐ＜０．０５）、总有效率（Ｐ＜０．０１）明显提高。结论：本疗法疗效理想，应用方便，副反应轻而少。

Objective: To study the effect and the safety of low molecular weight heparin (LMWH) on the treatment of acute cerebral infarction Methods: 60 cases with cerebral infarction within 48 hours of onset were randomly divided into LMWH treated group and control group (treated with conventional therapy) Results: Both the cure rate and the total effective rate were significantly higher in the LMWH treated group than in the control group ( P <0 05 or P <0 01) Conclusion: Not only the treatment of acute cerebral infarction with LMWH is effective, convenient and safe, but also has little side effects It could be widely used in clinical practice